Relation of markers of inflammation (C-reactive protein,white blood cell count,and lipoprotein-associated phospholipase A2) to the ankle brachial index

Abstract

Markers of inflammation are predictive of cardiovascular events but their association with atherosclerotic burden remains poorly defined. We hypothesized that markers of inflammation, including C-reactive protein (CRP), white blood cell (WBC) count, and lipoprotein-associated phospholipase A2 (Lp-PLA2), would be associated with the ankle-brachial index (ABI), a marker of atherosclerotic burden. Subjects were 247 patients referred for lower extremity arterial evaluation to the non-invasive vascular laboratory excluding those with active infection or lower extremity revascularization within the previous year. ABI was measured at two sites in both legs and the lowest of four measurements was used in the analyses. CRP was measured by a high-sensitivity immunoturbidimetric assay and Lp-PLA2 was measured by ELISA. The mean patient age was 68±11 years, and 54% were men. Mean ABI was 0.84-0.31 and 49% had an ABI < 0.9. Age, hypertension, fasting plasma glucose, and ‘ever’ smoking were independently associated with the ABI. Spearman correlation coefficients of inflammatory markers with the ABI were: CRP (r ¹/4-0.15, p ¹/4-0.02), WBC count (r ¹/4-0.27, p ¹/4-0.001), and Lp-PLA2 (r ¹/4-0.09, p ¹/4-0.21). In a multiple regression model that included conventional risk factors and statin use, CRP and WBC count were no longer significantly associated with ABI, whereas Lp-PLA2 was a borderline-significant predictor of lower ABI (p ¹/4-0.05). These data indicate that CRP and WBC count are not independently associated with ABI, a marker of atherosclerotic burden in subjects referred for non-invasive lower extremity arterial evaluation. The association of Lp-PLA2 with ABI merits further study.

Keywords

ankle-brachial index atherosclerosis C-reactive protein white blood cells

References

Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.

Hirsch AT , Criqui MH , Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.

Aronow WS , Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or =62 years of age. Am J Cardiol 1994; 74: 64-65.

Zheng ZJ , Sharrett AR , Chambless LE et al. Associations of ankle brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 115-125.

Ridker PM , Cushman M , Stampfer MJ , Tracy RP , Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-999.

Danesh J , Collins R , Appleby P , Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.

Ridker PM , Rifai N , Rose L , Buring JE , Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.

Folsom AR , Pankow JS , Tracy RP et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88: 112-117.

Caslake MJ , Packard CJ , Suckling KE et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 2000; 150: 413-419.

10.

Packard CJ , O’Reilly DS , Caslake MJ et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000; 343: 1148-1155.

11.

Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000; 343: 1179-1182.

12.

McConnell JP , Branum EL , Ballman KV et al. Gender differences in C-reactive protein concentrations - confirmation with two sensitive methods. Clin Chem Lab Med 2002; 40: 56-59.

13.

McDermott MM , Green D , Greenland P et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 194-199.

14.

Ariyo A , Hennekens CH , Stampfer MJ , Ridker PM. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician’s Health Study. J Cardiovasc Risk 1998; 5: 273-278.

15.

Van der Meer IM , de Maat MPM , Hak AE et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The Rotterdam Study. Stroke 2002; 33: 2750-2755.

16.

Rossi E , Biasucci LM , Citterio F et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002; 105: 800-803.

17.

Langlois M , Duprez D , Delanghe J , De Buyzere M , Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001; 103: 1863-1868.

18.

Cao Y , Stafforini DM , Zimmerman GA , McIntyre TM , Prescott SM. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 1998; 273: 4012-4020.

19.

Macphee CH. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr Opin Pharmacol 2001; 1: 121-125.

20.

Macphee CH , Suckling KE. Lipoprotein-associated phospholipase A(2): a target directed at the atherosclerotic plaque. Expert Opin Ther Targets 2002; 6: 309-314.

21.

Blake GJ , Dada N , Fox JC et al. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women. J Am Coll Cardiol 2001; 38: 1302-1306.

22.

Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.

23.

Park R , Detrano R , Xiang M et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002; 106: 2073-2077.